Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 21;12(14):4815.
doi: 10.3390/jcm12144815.

Effectiveness of Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease Therapy: Focusing on Traditional Medical Practices

Affiliations

Effectiveness of Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease Therapy: Focusing on Traditional Medical Practices

Katrina O Tonga et al. J Clin Med. .

Abstract

Chronic obstructive pulmonary disease (COPD) is a complex and serious disease that is characterized by dyspnea, fatigue, decreased exercise tolerance, peripheral muscle dysfunction, and mood disorders. These manifestations are successfully treated with pulmonary rehabilitation, a comprehensive intervention and holistic approach designed to improve the physical and psychological condition of people with COPD. Exercise is a big component of pulmonary rehabilitation programs, but the efficacy of non-traditional forms of exercise as used in alternative medicine is poorly understood. Here, we aim to address this gap in knowledge and summarize the clinical evidence for the use of traditional exercise regimens in the pulmonary rehabilitation of COPD patients.

Keywords: COPD; acupuncture; exercise training; oxygen support; pulmonary rehabilitation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Rao W., Wang S., Duleba M., Niroula S., Goller K., Xie J., Mahalingam R., Neupane R., Liew A.-A., Vincent M., et al. Regenerative Metaplastic Clones in COPD Lung Drive Inflammation and Fibrosis. Cell. 2020;181:848–864.e18. doi: 10.1016/j.cell.2020.03.047. - DOI - PMC - PubMed
    1. Wang C., Zhou J., Wang J., Li S., Fukunaga A., Yodoi J., Tian H. Progress in the mechanism and targeted drug therapy for COPD. Signal Transduct. Target. Ther. 2020;5:248. doi: 10.1038/s41392-020-00345-x. - DOI - PMC - PubMed
    1. Guo P., Li R., Piao T.H., Wang C.L., Wu X.L., Cai H.Y. Pathological Mechanism and Targeted Drugs of COPD. Int. J. Chronic Obstr. Pulm. Dis. 2022;17:1565–1575. doi: 10.2147/COPD.S366126. - DOI - PMC - PubMed
    1. Linden D., Guo-Parke H., Coyle P.V., Fairley D., McAuley D.F., Taggart C.C., Kidney J. Respiratory viral infection: A potential “missing link” in the pathogenesis of COPD. Eur. Respir. Rev. 2019;28:180063. doi: 10.1183/16000617.0063-2018. - DOI - PMC - PubMed
    1. Tanabe N., Sato S., Muro S., Shima H., Oguma T., Tanimura K., Sato A., Hirai T. Regional lung deflation with increased airway volume underlies the functional response to bronchodilators in chronic obstructive pulmonary disease. Physiol. Rep. 2019;7:e14330. doi: 10.14814/phy2.14330. - DOI - PMC - PubMed

LinkOut - more resources